Citation 79975

SHIROTA,O: TAKIZAWA,K: SEKITA,S: SATAKE,M: HIRAYAMA,Y: HAKAMATA,Y: HAYASHI,T: YANAGAWA,T:. (1997). ANTIANDROGENIC NATURAL DIELS - ALDER-TYPE ADDUCTS FROM BROSIMUM RUBESCENS.. 60(10)

Citation Details

Title	ANTIANDROGENIC NATURAL DIELS - ALDER-TYPE ADDUCTS FROM BROSIMUM RUBESCENS.
Authors	SHIROTA,O: TAKIZAWA,K: SEKITA,S: SATAKE,M: HIRAYAMA,Y: HAKAMATA,Y: HAYASHI,T: YANAGAWA,T:
Year	1997
Volume	60
Issue	10

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Brosimum rubescens (MORACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PALODESANGREN A	None
2	APPETITE STIMULANT	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN A	WEAK ACTIVITY
4	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN A	INACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PALODESANGREN B	None
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PALODESANGREN C	None
7	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN B	WEAK ACTIVITY
8	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN B	INACTIVE
9	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN C	WEAK ACTIVITY
10	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN C	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PALODESANGREN D	None
12	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PALODESANGREN E	None
13	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN D	ACTIVE
14	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN D	ACTIVE
15	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN E	ACTIVE
16	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALODESANGREN E	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	XANTHYLETIN	None
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AEGELINOL,(R):	None
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SUBEROSIN,7-DEMETHYL:	None

Show SPARQL Queries (1)